Inventor · disambiguated record
Aniko Redman
Also filed as: REDMAN ANIKO · REDMAN ANIKO M
11 granted patents·10 pending applications·328 citations·filing 1998–2013
92Inventor score
Top patents by PatentIndex Score
21 records- 0196US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0294US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 0388US6344476B1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 1998·Granted Feb 5, 2002·82 cites·18 claims
- 0487US8466283B2Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisHENTEMANN MARTIN·Filed 2007·Granted Jun 18, 2013·19 cites·47 claims
- 0586USRE46856ESubstituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2007·Granted May 22, 2018·9 cites·57 claims
- 0686US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 0785US7557129B2Cyanopyridine derivatives useful in the treatment of cancer and other disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Jul 7, 2009·18 cites·18 claims
- 0883US6353006B1Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agentsBAYER AG·Filed 1999·Granted Mar 5, 2002·33 cites·7 claims
- 0979US8859572B2Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesisHENTEMANN MARTIN F·Filed 2009·Granted Oct 14, 2014·9 cites·16 claims
- 1078US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 1176US7981903B22-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancerGLAXOSMITHKLINE LLC·Filed 2008·Granted Jul 19, 2011·4 cites·17 claims
- 1261US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 1360US2010160371A1Inhibition of p38 kinase activity by aryl ureasRANGES GERALD·Filed 2009·Application pending·0 cites
- 1459US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 1555US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 1653US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 1753US2013261113A1Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 1847US2012149706A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 1946US2002103253A1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 2001·Application pending·0 cites
- 2042US2008293696A12-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic AgentsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 2141US2003207865A1Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agentsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aniko Redman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →